BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mohamet L, Miazga NJ, Ward CM. Familial Alzheimer’s disease modelling using induced pluripotent stem cell technology. World J Stem Cells 2014; 6(2): 239-247 [PMID: 24772250 DOI: 10.4252/wjsc.v6.i2.239]
URL: https://www.wjgnet.com/1948-0210/full/v6/i2/239.htm
Number Citing Articles
1
V C Jones, R Atkinson-Dell, A Verkhratsky, L Mohamet. Aberrant iPSC-derived human astrocytes in Alzheimer's diseaseCell Death & Disease 2017; 8(3): e2696 doi: 10.1038/cddis.2017.89
2
Anna Slanzi, Giulia Iannoto, Barbara Rossi, Elena Zenaro, Gabriela Constantin. In vitro Models of Neurodegenerative DiseasesFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00328
3
Ghanshyam Upadhyay, Sharmila Shankar, Rakesh K. Srivastava. Stem Cells in Neurological Disorders: Emerging Therapy with Stunning HopesMolecular Neurobiology 2015; 52(1): 610 doi: 10.1007/s12035-014-8883-6
4
Lisa Mohamet, Vicky C Jones, Govindan Dayanithi, Alexei Verkhratsky. Pathological Human Astroglia in Alzheimer's Disease: Opening New Horizons with Stem Cell TechnologyFuture Neurology 2018; 13(2): 87 doi: 10.2217/fnl-2017-0029
5
Shyanne Page, Ronak Patel, Snehal Raut, Abraham Al-Ahmad. Neurological diseases at the blood-brain barrier: Stemming new scientific paradigms using patient-derived induced pluripotent cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(4): 165358 doi: 10.1016/j.bbadis.2018.12.009
6
Mercedes A. Hernández-Sapiéns, Edwin E. Reza-Zaldívar, Ricardo R. Cevallos, Ana L. Márquez-Aguirre, Karlen Gazarian, Alejandro A. Canales-Aguirre. A Three-Dimensional Alzheimer’s Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1Frontiers in Cellular Neuroscience 2020; 14 doi: 10.3389/fncel.2020.00151
7
Panetha Pansri, Phetcharat Phanthong, Nopparat Suthprasertporn, Yindee Kitiyanant, Alisa Tubsuwan, Andras Dinnyes, Julianna Kobolak, Narisorn Kitiyanant. Brain-derived neurotrophic factor increases cell number of neural progenitor cells derived from human induced pluripotent stem cellsPeerJ 2021; 9: e11388 doi: 10.7717/peerj.11388
8
Se Hoon Choi, Young Hye Kim, Luisa Quinti, Rudolph E. Tanzi, Doo Yeon Kim. 3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”Molecular Neurodegeneration 2016; 11(1) doi: 10.1186/s13024-016-0139-7
9
Pernille S. Lassen, Camilla Thygesen, Martin R. Larsen, Stefan J. Kempf. Understanding Alzheimer's disease by global quantification of protein phosphorylation and sialylated N-linked glycosylation profiles: A chance for new biomarkers in neuroproteomics?Journal of Proteomics 2017; 161: 11 doi: 10.1016/j.jprot.2017.04.003
10
Se Hoon Choi, Carla D’Avanzo, Young Hye Kim, Enjana Bylykbashi, Matthias Hebisch, Oliver Brüstle, Ruldolph E. Tanzi, Doo Yeon Kim. Stem Cell Technologies in NeuroscienceNeuromethods 2017; 126: 1 doi: 10.1007/978-1-4939-7024-7_1
11
Christos Tsagkaris, Dimitrios V. Moysidis, Andreas S. Papazoglou, Andleeb Khan, Stavros Papadakos, Anna Maria Louka, Dorothy Martha Scordilis, Anastasiia Shkodina, Kyriakoula Varmpompiti, Gaber El-Saber Batiha, Athanasios Alexiou. Proteins Associated with Neurodevelopmental DisordersNutritional Neurosciences 2022; : 311 doi: 10.1007/978-981-15-9781-7_14
12
Xianmin Zeng, Joshua G. Hunsberger, Anton Simeonov, Nasir Malik, Ying Pei, Mahendra Rao. Concise Review: Modeling Central Nervous System Diseases Using Induced Pluripotent Stem CellsStem Cells Translational Medicine 2014; 3(12): 1418 doi: 10.5966/sctm.2014-0102
13
Snehal Raut, Ronak Patel, Abraham J. Al-Ahmad. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitroFluids and Barriers of the CNS 2021; 18(1) doi: 10.1186/s12987-020-00235-y
14
Ling Li, Hee Jin Kim, Jee Hoon Roh, Minchul Kim, Wonyoung Koh, Younghoon Kim, Hyohoon Heo, Jaehoon Chung, Mahito Nakanishi, Taeyoung Yoon, Chang Pyo Hong, Sang Won Seo, Duk L. Na, Jihwan Song. Pathological manifestation of the induced pluripotent stem cell‐derived cortical neurons from an early‐onset Alzheimer's disease patient carrying a presenilin‐1 mutation (S170F)Cell Proliferation 2020; 53(4) doi: 10.1111/cpr.12798
15
Carla D'Avanzo, Jenna Aronson, Young Hye Kim, Se Hoon Choi, Rudolph E. Tanzi, Doo Yeon Kim. Alzheimer's in 3D culture: Challenges and perspectivesBioEssays 2015; 37(10): 1139 doi: 10.1002/bies.201500063
16
Jeremy Micah Crook, Gordon Wallace, Eva Tomaskovic-Crook. The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapyExpert Review of Neurotherapeutics 2015; 15(3): 295 doi: 10.1586/14737175.2015.1013096
17
Ling Li, Jee Hoon Roh, Hee Jin Kim, Hyun Jung Park, Minchul Kim, Wonyoung Koh, Hyohoon Heo, Jong Wook Chang, Mahito Nakanishi, Taeyoung Yoon, Duk L. Na, Jihwan Song. The First Generation of iPSC Line from a Korean Alzheimer's Disease Patient Carrying APP-V715M Mutation Exhibits a Distinct Mitochondrial DysfunctionExperimental Neurobiology 2019; 28(3): 329 doi: 10.5607/en.2019.28.3.329
18
Riya R. Kanherkar, Naina Bhatia-Dey, Evgeny Makarev, Antonei B. Csoka. Cellular reprogramming for understanding and treating human diseaseFrontiers in Cell and Developmental Biology 2014; 2 doi: 10.3389/fcell.2014.00067
19
Renzo J. M. Riemens, Edilene S. Soares, Manel Esteller, Raul Delgado-Morales. Neuroepigenomics in Aging and DiseaseAdvances in Experimental Medicine and Biology 2017; 978: 443 doi: 10.1007/978-3-319-53889-1_23